Oral SERDs for Breast Cancer | Erica Mayer, MD, MPH, FASCO

Posted on 04/30/2026
29:12 |

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oral SERDs for Breast Cancer | Faculty Presentation 2: Future Directions in the Use of Oral SERDs for HR-Positive, HER2-Negative BC — Erica Mayer, MD, MPH, FASCO

CME information and select publications